Cargando…

Melatonin for Atypical Antipsychotic-Induced Metabolic Adverse Effects: A Meta-Analysis of Randomized Controlled Trials

The objective of our study was to determine the effect of melatonin administration on atypical antipsychotic-induced metabolic adverse effects in patients with psychiatric disorders. A systematic search was performed in PUBMED, Cochrane Library, Scopus, Web of Science, and EBSCOhost electronic datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamath, Ashwin, Rather, Zahoor Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841109/ https://www.ncbi.nlm.nih.gov/pubmed/29682546 http://dx.doi.org/10.1155/2018/4907264

Ejemplares similares

Does Melatonin and Melatonin Agonists Improve the Metabolic Side Effects of Atypical Antipsychotics?: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Igwe, Stanley C., et al.
Publicado: (2018)

Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial
por: Sinkeviciute, Igne, et al.
Publicado: (2021)

Evaluation of acute effects of melatonin on ethanol drinking in ethanol naïve rats
por: Rather, Zahoor Ahmad, et al.
Publicado: (2015)

T219. THE ROLE OF MELATONIN AND MELATONIN AGONISTS IN COUNTERACTING ANTIPSYCHOTIC-INDUCED METABOLIC SIDE EFFECTS: A SYSTEMATIC REVIEW
por: Bahk, Won-Myong, et al.
Publicado: (2018)

Influence of the use of atypical antipsychotics in metabolic syndrome
por: Doménech-Matamoros, P
Publicado: (2020)

Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials
por: Hulshof, Tessa A., et al.
Publicado: (2018)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Analysis of Adverse Drug Reactions of Atypical Antipsychotic Drugs in Psychiatry OPD
por: Piparva, Kiran G., et al.
Publicado: (2011)

Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia
por: Khasawneh, Fadi T., et al.
Publicado: (2014)

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial
por: Liu, Chenchen, et al.
Publicado: (2021)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications
por: Llorca, Pierre-Michel, et al.
Publicado: (2017)

Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
por: Alvarez-Herrera, Samantha, et al.
Publicado: (2020)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?
por: Porfirio, Maria-Cristina, et al.
Publicado: (2017)

Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial
por: Goyal, Abhinav, et al.
Publicado: (2014)

Diabetic control and atypical antipsychotics: a case report
por: Gaston, Romina Lopez, et al.
Publicado: (2008)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials
por: Mansuri, Zeeshan, et al.
Publicado: (2022)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials
por: Derry, Sheena, et al.
Publicado: (2007)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans
por: Gubert, Priscila, et al.
Publicado: (2013)

Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
por: Carli, Marco, et al.
Publicado: (2021)

Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
por: Xu, Haiyun, et al.
Publicado: (2019)

Effect of safranal, a constituent of saffron, on olanzapine (an atypical antipsychotic) induced metabolic disorders in rat
por: Malekzadeh, Sara, et al.
Publicado: (2019)

Adverse effects and short-term developmental outcomes of infants exposed to atypical antipsychotics during breastfeeding
por: Sinha, Santosh Kumar, et al.
Publicado: (2021)

Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials
por: Grossman, Ehud, et al.
Publicado: (2011)

Atypical antipsychotics and delirium in critical care
por: Wise, Matt P, et al.
Publicado: (2011)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Constrictive Pericarditis Associated with Atypical Antipsychotics
por: Chen, Kuan-chin Jean, et al.
Publicado: (2012)

Pedal edema associated with atypical antipsychotics
por: Munshi, Santanu, et al.
Publicado: (2016)

Predictors of Effect of Atypical Antipsychotics on Speech
por: Sinha, Preeti, et al.
Publicado: (2015)

Clinical pharmacology of atypical antipsychotics: an update
por: Mauri, M.C., et al.
Publicado: (2014)

Anti-stress Properties of Atypical Antipsychotics
por: Sanson, Alice, et al.
Publicado: (2020)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics
por: Al-Aojan, S., et al.
Publicado: (2018)

Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials
por: Jiang, Wen-Long, et al.
Publicado: (2020)

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4d1i3nrb3noe6mc2nb9cajm2v0